Toshiji Igarashi

545 total citations
42 papers, 411 citations indexed

About

Toshiji Igarashi is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Toshiji Igarashi has authored 42 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Organic Chemistry. Recurrent topics in Toshiji Igarashi's work include Animal testing and alternatives (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Free Radicals and Antioxidants (3 papers). Toshiji Igarashi is often cited by papers focused on Animal testing and alternatives (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Free Radicals and Antioxidants (3 papers). Toshiji Igarashi collaborates with scholars based in Japan and China. Toshiji Igarashi's co-authors include Shinzaburo Ohtake, Tadao Shoji, Yasuhiro Akiyama, Hidetoshi Kawashima, Satoru Tanaka, N. MINAMI, Masayuki Matsukura, Takashi Yamanaka, Masatoshi Fujimoto and M.T. Murakami and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Carcinogenesis.

In The Last Decade

Toshiji Igarashi

41 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiji Igarashi Japan 11 130 73 59 56 55 42 411
H. Roger Brown United States 12 381 2.9× 175 2.4× 21 0.4× 26 0.5× 16 0.3× 22 696
James E. Grace United States 13 145 1.1× 45 0.6× 34 0.6× 98 1.8× 10 0.2× 21 555
Tsuneo Wakabayashi Japan 11 201 1.5× 69 0.9× 32 0.5× 11 0.2× 13 0.2× 40 480
S. Raab Switzerland 12 207 1.6× 66 0.9× 53 0.9× 8 0.1× 22 0.4× 16 463
Aisar Atrakchi United States 15 137 1.1× 43 0.6× 11 0.2× 34 0.6× 26 0.5× 26 460
Yusaku Komoike Japan 15 93 0.7× 70 1.0× 40 0.7× 22 0.4× 16 0.3× 21 579
Rakesh Nagilla United States 12 263 2.0× 41 0.6× 51 0.9× 8 0.1× 36 0.7× 27 649
Jerzy Wiśniewski Poland 17 273 2.1× 85 1.2× 22 0.4× 30 0.5× 8 0.1× 54 677
George Lukas Switzerland 7 97 0.7× 41 0.6× 31 0.5× 9 0.2× 17 0.3× 12 445
I. Glenn Sipes United States 11 145 1.1× 32 0.4× 19 0.3× 10 0.2× 15 0.3× 15 581

Countries citing papers authored by Toshiji Igarashi

Since Specialization
Citations

This map shows the geographic impact of Toshiji Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiji Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiji Igarashi more than expected).

Fields of papers citing papers by Toshiji Igarashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiji Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiji Igarashi. The network helps show where Toshiji Igarashi may publish in the future.

Co-authorship network of co-authors of Toshiji Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiji Igarashi. A scholar is included among the top collaborators of Toshiji Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiji Igarashi. Toshiji Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukidate, Kazuo, et al.. (1999). Mechanism of weight gain suppressing effect of ER-40133, an angiotensin I converting enzyme inhibitor, in growing rats.. The Journal of Toxicological Sciences. 24(1). 45–53. 6 indexed citations
2.
Hayashi, Yutaka, Mamoru Nomura, Toshiji Igarashi, et al.. (1997). A survey of the values of clinical chemistry parameters obtained for a common rat blood sample in ninety-eight japanese laboratories.. The Journal of Toxicological Sciences. 22(1). 25–44. 17 indexed citations
3.
Mizuguchi, Kiyoshi, et al.. (1996). Update of general pharmacology/safety pharmacology studies in Japan. Drug Development Research. 38(2). 114–115. 2 indexed citations
4.
Igarashi, Toshiji, et al.. (1996). Case Studies for Statistical Analysis of Toxicokinetic Data. Regulatory Toxicology and Pharmacology. 23(3). 193–208. 9 indexed citations
5.
Igarashi, Toshiji, et al.. (1996). Study design and statistical analysis of toxicokinetics: A report of JPMA investigation of case studies.. The Journal of Toxicological Sciences. 21(5). 497–504. 11 indexed citations
6.
Igarashi, Toshiji. (1995). The rationale for using logarithmic transformation of concentration data in toxicokinetic studies.. The Journal of Toxicological Sciences. 20(1). 67–72. 4 indexed citations
7.
Igarashi, Toshiji, et al.. (1995). Predictability of clinical adverse reactions of drugs by general pharmacology studies.. The Journal of Toxicological Sciences. 20(2). 77–92. 46 indexed citations
8.
Kawaguchi, Takashi, et al.. (1994). Effects of a daily feeding-restriction on the reproductive and development toxicity parameters in female rats.. The Journal of Toxicological Sciences. 19(4). 181–187. 5 indexed citations
9.
Kato, Ryuichi, David Case, Kosei NODA, et al.. (1993). Toxicokinetics: Its significance and practical problems.. The Journal of Toxicological Sciences. 18(4). 211–238. 3 indexed citations
11.
Takeda, Mikio, et al.. (1983). . Folia Pharmacologica Japonica. 82(5). 343–350. 1 indexed citations
12.
Igarashi, Toshiji, et al.. (1982). Induction of hepatic gamma-glutamyl transpeptidase in rats by repeated administration of aminopyrine.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 795–800. 8 indexed citations
13.
Murakami, M.T., et al.. (1981). Effects of azelastine hydrochloride, a new antiallergic drug, on the gastrointestinal tract.. PubMed. 31(8). 1203–6. 18 indexed citations
14.
Igarashi, Toshiji, et al.. (1979). Antihypertensive action of d,l-alpha-tocopheryl nicotinate in rats.. Journal of Nutritional Science and Vitaminology. 25(3). 159–173. 3 indexed citations
15.
Kawashima, Hidetoshi, et al.. (1978). Chronic hypertension induced by streptozotocin in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 305(2). 123–126. 60 indexed citations
16.
Igarashi, Toshiji, et al.. (1977). Antihypertensive effect of combined treatment with .ALPHA.- and .BETA.-adrenergic blockers in the spontaneously hypertensive rat.. Japanese Circulation Journal. 41(8). 903–911. 25 indexed citations
17.
Fujimoto, Masatoshi, et al.. (1976). Protective effect of tocopheryl esters on pulmonary edema induced by epinephrine infusion in mice. Folia Pharmacologica Japonica. 72(1-2). 15–21. 2 indexed citations
18.
Igarashi, Toshiji, et al.. (1976). Anti-Hypertensive Action of dl-α-Tocopheryl Esters in Rats. Clinical Science. 51(s3). 163s–164s. 1 indexed citations
19.
Igarashi, Toshiji, et al.. (1972). Effects of Coenzyme Q10 on experimental hypertension in the Desoxycorticosterone acetate-saline loaded rats. Folia Pharmacologica Japonica. 68(4). 460–472. 6 indexed citations
20.
Igarashi, Toshiji, et al.. (1969). Pharmacological studies on the bronchodilator, isoprophenamine. Folia Pharmacologica Japonica. 65(2). 93–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026